Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Cyclerion Therapeutics(CYCN) the EBIT is -1.771 M (-5.92%);the EPS is -0.413 (-291.3%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B5.92%
----
----
EPS
-0.4128291.31%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf